For AI assistants & researchers — machine-readable summary of this page
What this page is: Delvantic's full research page for Accenture plc Class A (ACN) — AI-driven forensic equity research: mechanical valuation models (DCF, EPV, anchored-PE, scenario) plus three independent AI lenses (Quality / Value / Sentiment). Everything below is rendered server-side; you are not missing content that requires JavaScript. All scores are predictions and research opinions, not financial advice.
Our current read (analysis of 2026-08-23): Designation Gem · Gem Score +43 (−100…+100 Quality+Value blend) · Quality 73 · Value 18 · Sentiment 53 (timing only, not weighted) · Composite fair value $193.32 vs $185.26 at analysis
Page map (sections in order; each card carries a stable
reference-name attribute you can cite):
profile-header/price-overview— company profile, live quote, market capextended-analysis— the core: three AI lens reads with findings, scores, and the analyst memofuture-predictions— our forward price-band predictionsmarket-narrative/ai-findings/gpt-critique— narrative context, cross-model findings, and an adversarial critique of our own analysis (near the end of the document)- Members-only sections (render as login gates for anonymous readers):
price-history,income-trend,key-metrics,financials(statement tables),insider-trading. The analysis above is public; the raw data tables require a free account.
More for machine readers: site briefing at
/llms.txt ·
any ticker resolves at delvantic.com/stock/TICKER ·
raw inputs are public-company filings and market data (via licensed data feeds);
every model, score, lens read, and prediction on this page is Delvantic's own analysis.
Accenture plc Class A
ACN NYSEAccenture plc Class A is a global professional services company focused on helping organizations modernize operations, strengthen digital capabilities, and improve business performance. Accenture provides services across strategy and consulting, technology, operations, digital transformation, cybersecurity, cloud, data, and artificial intelligence, serving clients in industries such as financial services, healthcare, public service, communications, consumer goods, and manufacturing. Its work centers on designing and delivering enterprise-scale solutions that integrate business process expertise with advanced technology and industry knowledge. Accenture also supports clients through specialized offerings in supply chain, finance, talent, and customer experience, making it a major provider of end-to-end business services for corporations and governments worldwide. Headquartered in Dublin, Ireland, Accenture plc Class A represents a widely followed name in the information technology services and consulting market.
Price Overview
Price History (1 Year)
Revenue & Net Income Trend
| Period | Revenue | Net Income | Net Margin | YoY/QoQ |
|---|
Key Metrics
EPS (Diluted): 12.15
Total Equity: $32.24B
Shares: 632,435,108
Total Debt: $114.48M
Cash: $11.48B
EBITDA: N/A
Total Debt: $114.48M
Cash: $11.48B
Revenue: $69.67B
Revenue: $69.67B
Revenue: $69.67B
Total Equity: $32.24B
Tax Rate: 23.7%
Equity: $32.24B
Total Debt: $114.48M
Cash: $11.48B
Current Liabilities: $20.35B
Long-Term Debt: $0.00
Total Debt: $114.48M
Total Equity: $32.24B
Shares: 632,435,108
Shares: 632,435,108
CapEx: -$600.04M
Shares: 632,435,108
Stock Price: $185.28
Net Income: $7.68B
Industry Benchmarks
Income Statement (Annual)
Last updated: Aug 22, 2026 2:06pm (1d ago)| Metric | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | $50.5B | $61.6B | $64.1B | $64.9B | $69.7B |
| Cost of Revenue | $34.2B | $41.9B | $43.4B | $43.7B | $47.4B |
| Gross Profit | $16.4B | $19.7B | $20.7B | $21.2B | $22.2B |
| Operating Expenses | $8.7B | $10.3B | $11.9B | $11.6B | $12.0B |
| Operating Income | $7.6B | $9.4B | $8.8B | $9.6B | $10.2B |
| Net Income | $5.9B | $6.9B | $6.9B | $7.3B | $7.7B |
| EBITDA | $8.7B | $10.7B | $10.2B | $11.0B | — |
| EPS | $9.31 | $10.87 | $10.90 | $11.57 | $12.29 |
| EPS (Diluted) | $9.16 | $10.71 | $10.77 | $11.44 | $12.15 |
Balance Sheet (Annual)
Last updated: Aug 22, 2026 1:53pm (1d ago)| Metric | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Cash & Equivalents | $8.2B | $7.9B | $9.0B | $5.0B | $11.5B |
| Total Current Assets | $19.7B | $21.6B | $23.4B | $20.9B | $28.9B |
| Total Assets | $43.2B | $47.3B | $51.2B | $55.9B | $65.4B |
| Current Liabilities | $15.7B | $17.5B | $18.0B | $19.0B | $20.4B |
| Long-Term Debt | — | — | — | — | — |
| Total Liabilities | $23.1B | $24.5B | $24.8B | $26.8B | $33.2B |
| Total Equity | $20.1B | $22.7B | $26.5B | $29.2B | $32.2B |
| Retained Earnings | $14.0B | $18.2B | $19.3B | $23.1B | $21.0B |
Cash Flow (Annual)
Last updated: Aug 22, 2026 2:06pm (1d ago)| Metric | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Operating Cash Flow | $9.0B | $9.5B | $9.5B | $9.1B | $11.5B |
| Capital Expenditure | -$580.1M | -$718.0M | -$528.2M | -$516.5M | -$600.0M |
| Free Cash Flow | $8.4B | $8.8B | $9.0B | $8.6B | $10.9B |
| Acquisitions (net) | — | — | — | — | — |
| Net Debt Issued / (Repaid) | — | $0 | $100.0M | $827.8M | $4.1B |
| Dividends Paid | -$2.2B | -$2.5B | — | — | — |
| Stock Buybacks | -$3.7B | -$4.1B | -$4.3B | -$4.5B | -$4.6B |
| Net Change in Cash | -$247.2M | -$278.3M | $1.2B | -$4.0B | $6.5B |
Growth Trends (YoY %)
Last updated: Aug 22, 2026 2:06pm (1d ago)| Metric | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Revenue Growth | +21.9% | +4.1% | +1.2% | +7.4% |
| Gross Profit Growth | +20.4% | +5.2% | +2.1% | +5.1% |
| Operating Income Growth | +22.9% | -5.9% | +8.9% | +6.6% |
| Net Income Growth | +16.4% | -0.1% | +5.7% | +5.7% |
| EBITDA Growth | +22.1% | -4.3% | +8.0% | — |
Dividend History (Last 20)
Last updated: Aug 17, 2026 9:47am (6d ago)| Date | Dividend | Declaration | Record | Payment |
|---|---|---|---|---|
| 2026-07-09 | $1.63 | — | — | — |
| 2026-04-09 | $1.63 | — | — | — |
| 2025-07-10 | $1.48 | — | — | — |
| 2025-04-10 | $1.48 | — | — | — |
| 2025-01-16 | $1.48 | — | — | — |
| 2024-10-10 | $1.48 | — | — | — |
| 2024-07-11 | $1.29 | — | — | — |
| 2024-04-10 | $1.29 | — | — | — |
| 2024-01-17 | $1.29 | — | — | — |
| 2023-10-11 | $1.29 | — | — | — |
| 2023-07-12 | $1.12 | — | — | — |
| 2023-04-12 | $1.12 | — | — | — |
| 2023-01-11 | $1.12 | — | — | — |
| 2022-10-12 | $1.12 | — | — | — |
| 2022-07-13 | $0.97 | — | — | — |
| 2022-04-13 | $0.97 | — | — | — |
| 2022-01-12 | $0.97 | — | — | — |
| 2021-10-13 | $0.97 | — | — | — |
| 2021-07-14 | $0.88 | — | — | — |
| 2021-04-14 | $0.88 | — | — | — |
Deep Analysis
Risk : Reward — if the last quarter repeats
Live · as of 2026-08-23 02:38Recovery pays +12%; another quarter like the worst recent one costs 41%. Ratio 0.3:1.
| Case | Growth | Margin | Fair value | vs price ($185.26) |
|---|---|---|---|---|
| Bull — recovery | +8% | 17.0% | $207.45 | +12% |
| Base — stabilizes | +6% | 14.7% | $166.87 | -10% |
| Bear — keeps slipping | +3% | 12.5% | $131.73 | -29% |
| Stress — last quarter repeats | +7% | 8.7% | $109.89 | -41% |
Narrative Economics
market-narrative step).
AI Lens 4th lens · how AI reaches this business · 5-yr
2026-08-17Enterprises cannot self-assemble AI across legacy data estates, ERP, security and change management, so Accenture harvests a re-platforming wave — its GenAI-tagged bookings and share gain (7.4% vs 3.9% industry) show it is currently the trusted integration layer for models it does not have to build.
The monetized unit is billable people on a pyramid: if agents cut the hours needed for application development, testing, maintenance and BPO transaction processing, competitive bidding hands the savings to clients as lower contract values, not to Accenture as margin.
Whether Accenture converts pricing from hours/FTEs to outcome- and asset-based contracts fast enough to hold revenue per delivered outcome. Watch revenue per employee and managed-services renewal values against headcount — rising revenue/head with flat-to-down headcount is the tell it is working.
Master service agreements, procurement approval and security posture inside thousands of large enterprises, plus global delivery scale, government clearances and a decade of client-specific system knowledge — none of which cheap software confers.
AI Lens thesis
AI reaches Accenture on both sides of the same P&L line: demand-side it creates a large, multi-year integration and data-remediation program that only firms with existing enterprise access can execute, and Accenture is visibly winning that share; supply-side it attacks the cost basis of the very work it sells, because roughly half of revenue is managed services and offshore delivery whose price is anchored to headcount and labor arbitrage. Gross margin has sat at ~32% and operating margin ~15% for five years, which is the empirical signal that in a bid-driven services market productivity gains historically pass through to clients rather than to shareholders. So the decisive question is not capability — Accenture will ship good AI work — but whether it can re-price from time to outcome before AI-native, low-headcount challengers and hyperscaler/model-vendor professional services arms reset the reference price for a transformation program.
What the market may be underestimating
Upside Accenture's own delivery cost is the largest AI-addressable cost pool in the sector — if AI absorbs the bottom of the pyramid, a firm that has never grown operating margin past ~15% could re-rate on structurally higher margin rather than volume.
Downside BPO/Operations transaction-based contracts are the quietest exposure: clients can benchmark agentic per-transaction cost directly, making price resets mechanical and contractual rather than negotiated, and those are multi-year annuity revenues the market treats as defensive.
Outcome range spread 54 · unresolved
Growth Outlook
Analyzed 2026-08-22 14:13The question every valuation on this page silently assumes: is this company likely to grow? Judged forward — the business, its category, the world — against what's already printed.
Claude Reading
Looking at the raw quarterlies first: revenue went $16.41B → $17.69B → $16.66B → $17.73B → $17.60B → $18.74B → $18.04B → $18.72B. That's roughly 7% YoY in the most recent quarter (May '26 $18.72B vs May '25 $17.73B, +5.6%) and Nov '25 $18.74B vs Nov '24 $17.69B (+5.9%). The Feb quarter was softer at 10.1% net margin — the seasonal dip persists — but full-year FY25 delivered $69.67B rev and $7.68B NI, up 7.3% and 5.8% respectively from FY24. This is not a company in trouble; it's a company growing mid-single-digits with a 14.7% op margin and ~$10.9B FCF against a $113B market cap (10.4x FCF yield ~9.6%). Balance sheet is essentially debt-free ($114.5M debt vs $11.5B cash), ROIC 37%, and they pay a 3.4% dividend. At 15.2x trailing earnings for a business of this quality, the setup is genuinely cheap by ACN's own history (typical 22-28x).
Now, the models. Synthesis says undervalued with fair value $193-232; Market Forces says neutral/hold pending sub-13x forward; Narrative layer calls it a sentiment gap not a broken business. I think Synthesis is directionally right but the $232 signal-adjusted number is aggressive — that requires believing multiple re-rates back toward 20x without any hit to growth from GenAI. Market Forces' demand for sub-13x forward is too punitive for a business generating 37% ROIC with net cash; you don't get to buy this at Cognizant multiples absent a real thesis break. The models are internally inconsistent: you can't simultaneously call this "above sector benchmarks" with "strong cash flow quality" and demand a deep-cyclical multiple. My read: fair value sits around $205-220 on 17-18x FY26 EPS (~$12.50-13), giving 10-18% upside plus 3.4% yield. That's a decent risk/reward but not a table-pounder.
The contrarian case deserves airtime and the models underweight it. GenAI consulting is a double-edged sword: yes, ACN is winning $3B+ in GenAI bookings, but the deflationary risk is real — if a $50M SAP implementation becomes a $20M Copilot-assisted engagement, revenue per engagement compresses even as project count rises. Bookings growth has been decelerating (management flagged this on recent calls) and the Feb '26 margin of 10.1% is notably worse than Feb '25's 10.7% and Feb '24 comparable — the "seasonal" dip is deepening. Federal consulting exposure (~8% of Americas) is a live headwind given DOGE-related contract reviews. The insider data here is useless (all award grants, tiny sizes, no open-market buying to confirm conviction). And "recent_revenue_yoy 7.4%" flatters the picture — TTM revenue growth is closer to 5%, and organic (ex-acquisitions, ACN has done ~30 tuck-ins) is likely 3-4%. The bear "value trap at 3-4% organic growth" framing is not crazy.
Where I land: partial agreement with the undervalued verdict, but the synthesis' +25% upside is overstated. This is a $200-215 stock on fundamentals with a 3.4% dividend cushion, trading at $185 with real but manageable GenAI-transition risk. The asymmetry favors accumulation — downside to $165 (13.5x, prior cycle trough) is ~11%, upside to $215 is ~16%, plus yield. That's not screaming cheap; it's quietly cheap for patient capital willing to underwrite mid-single-digit growth continuing. I'd want to see the next bookings number and organic growth disclosure before sizing up. The models overweight the DCF math and underweight the real possibility that consulting economics structurally reset lower — but even in that scenario, at 15x with net cash and 100% FCF conversion, you're not losing much.
GPT Reading
At $185, Accenture looks mispriced to the downside for what the numbers actually show. This is not a high-growth software company pretending to be one; it is a very large, asset-light services compounder producing roughly $70 billion of annual revenue, $10.2 billion of operating income, $7.7 billion of net income, and $10.9 billion of free cash flow with essentially no balance-sheet leverage. The cleanest fact in the file is the balance sheet: $11.48 billion of cash against just $114.5 million of debt. On an enterprise basis, you are paying barely 1.46x revenue for a business with 14.7% operating margin, 11.0% net margin, 23.8% ROE, and 37.4% ROIC. That is cheap for a commodity outsourcer, but Accenture’s economics are better than that label implies. The market cap of $113.4 billion against trailing earnings of $7.68 billion gives the 15.2x P/E shown, and that multiple feels much more like a cyclical industrial than a high-return global consulting franchise.
The recent operating trend is better than the “mature stagnation” framing. Annual revenue rose from $64.9 billion in FY24 to $69.7 billion in FY25, up 7.4%, while net income grew from $7.26 billion to $7.68 billion, up 5.8%. Quarterly revenue has also stair-stepped higher: from $16.41 billion in Aug-2024 to $17.69 billion, $16.66 billion, $17.73 billion, $17.60 billion, $18.74 billion, $18.04 billion, and now $18.72 billion. There is seasonality and some choppiness, but no evidence of a broken demand engine. More importantly, margins have held in a narrow band despite all the AI-disintermediation fear: recent quarterly net margins have been 12.9%, 10.7%, 12.4%, 8.0%, 11.8%, 10.1%, and 12.5%. Even the ugly August quarter looks more like a seasonal or mix-related dip than a structural deterioration. If generative AI were already commoditizing Accenture’s work at speed, I would expect a clearer margin slide than this.
Cash conversion is the second reason I lean bullish. FY25 operating cash flow was $11.47 billion on $7.68 billion of net income, and with only $600 million of capex, free cash flow reached $10.87 billion. That is a 15.6% FCF margin on revenue and implies the company converts accounting earnings into distributable cash extremely efficiently. With a 3.36% dividend yield and net cash balance sheet, shareholders are being paid while they wait for sentiment to normalize. The valuation also looks more favorable if you think in ex-cash terms: deducting the $11.48 billion cash from the equity value lowers the effective multiple further, yet the business still posted nearly $8 billion of annual profit. For a company that has grown revenue from $50.5 billion in 2021 to $69.7 billion in 2025, while keeping operating margins around 14%-15%, the current price embeds too much skepticism about future relevance.
The strongest argument against this view is that the business may simply deserve a lower multiple now than in prior cycles because growth has normalized and AI could compress billable hours over time. The five-year revenue CAGR of 4.3% and earnings CAGR of 5.7% are solid but not exciting, and FY22 to FY23 showed that operating income can slip even when revenue rises, with op income moving from $9.37 billion to $8.81 billion. That tells you this is not an invulnerable margin story. If clients use AI to demand the same project outcomes with fewer consultants, Accenture’s current 31.9% gross margin and 14.7% operating margin could face secular pressure. A 15x earnings multiple is not obviously absurd if you assume long-run growth drifts to low single digits and margin expansion disappears. In that framework, the stock is a bond proxy with modest growth, not a rerating candidate. I weigh that risk less heavily because the most recent annual and quarterly data do not yet show the feared economic damage; they show resilience, not erosion.
What would change my mind is straightforward. If revenue growth slips back toward 2%-3% while net margin falls below 10% on a sustained basis, the “cheap compounder” case breaks and this deserves to trade closer to 12x-13x earnings, or roughly $145-$160 depending on the earnings base. Likewise, if free cash flow drops materially below net income for more than a year, that would undermine one of the stock’s core supports. On the other hand, if Accenture can keep quarterly revenue around $18.5-$19.0 billion, sustain net margins near 11%-12%, and push annual EPS/NI growth back into high single digits, I think the market will eventually pay at least 17x-18x earnings again, which would support something like $205-$225 even without heroic assumptions.
Grok Reading
Accenture’s numbers describe a fortress-quality compounder that the market has marked down as if the franchise were breaking. Fiscal 2025 delivered $69.67B of revenue and $7.68B of net income on a $10.23B operating profit, converting almost perfectly into $10.87B of free cash flow after only $600M of capex. Trailing net margin sits at 11.0%, operating margin 14.7%, ROE 23.8% and ROIC an exceptional 37.4%, all while the balance sheet carries $11.48B of cash against a trivial $114.5M of debt. At $185 the stock trades at 15.2× earnings, 1.68× sales and a free-cash-flow yield near 9.6%—multiples that embed the assumption that mid-single-digit growth is about to disappear. Yet the last four reported quarters still show revenue between $17.6B and $18.7B, with the May 2026 quarter up roughly 5.6% year-over-year and net margin back at 12.5%. The 4.3% revenue CAGR and 5.7% earnings CAGR understate the cash-generation story: FCF has compounded at nearly 10%. This is not a broken model; it is a mature earner whose pricing power and client lock-in have so far absorbed the AI narrative scare without visible margin collapse.
The valuation gap is therefore mostly narrative. A 15× multiple on a business that historically commanded 25–30×, paired with a 3.4% dividend and net-cash balance sheet, implies the market believes GenAI will either hollow out consulting demand or force permanent fee compression. Nothing in the reported P&L yet confirms that thesis. Quarterly revenue is still expanding, cash conversion remains pristine, and the company continues to return capital without leverage. The decelerating sequential growth flag is real but modest; absolute dollar growth and backlog visibility have not cracked. At these cash yields the stock does not need a re-rating to 25× to work; even a move back toward 18–19× on stable mid-single-digit earnings growth produces attractive total returns.
The strongest counter-argument is that the multiple compression is rational and permanent. Revenue CAGR of only 4.3% and recent earnings growth of 5.7% look pedestrian for a technology name, and the “decelerating” quarterly trend plus macro headwinds could keep growth stuck in the low single digits for years. Hyperscalers and internal AI tools may slowly erode the higher-margin strategy and implementation work that has historically supported Accenture’s premium. If clients systematically demand productivity-linked pricing, the 14.7% operating margin could drift toward 12%, turning the current 15× P/E into a value trap rather than a bargain. The Market Forces note correctly flags that competitive and ROI risks are underappreciated at any multiple that still assumes historical margin durability. Insider activity is pure noise (tiny awards), offering no signal either way, and the valuation models themselves disagree—composite fair value of $193 versus a more optimistic signal-adjusted $232—so the margin of safety is thinner than a simple “cheap on cash flow” screen suggests.
I would reverse the undervalued call if two consecutive quarters showed revenue growth falling below 2% year-over-year while operating margin compressed below 13%, or if free-cash-flow conversion deteriorated materially below 90% of net income. A sustained re-acceleration above 8–9% organic growth with stable margins would, conversely, justify a higher conviction bull stance and a move toward the upper end of the fair-value range.
Big-3 Panel — where each AI stands
Advanced Analysis Forensic deep-dive · separate lenses
Revenue has grown every year from 50.5B in 2021 to 69.7B in 2025 (about 8% CAGR) with operating margin steady in a tight 13.7-15.2% band and net income compounding from 5.91B to 7.68B. Free cash flow reached a record 10.87B in 2025, converting at 141% of net income (OCF/NI 1.41x) with accruals at -5.4% of assets, Beneish M of -2.71 and Altman Z of 4.24 - a clean, non-manipulative earnings profile. The balance sheet holds 11.48B liquid cash and 11.37B net cash (about 10% of market cap), so the business is fully self-funding.
Verify before trusting this (5)
- Bookings and book-to-bill trend to confirm demand durability into FY26
- Segment / geography mix and whether GenAI-related bookings are cannibalizing legacy managed services
- Whether the 2025 gross margin dip reflects wage inflation, utilization, or pricing concessions
- Acquisition spend and goodwill build - ACN is an active tuck-in acquirer, so returns on M&A capital matter
- Customer concentration and public-sector exposure given federal contracting scrutiny
The price is $185.26 against a composite fair value of $193.32 (about 4% upside) and a signal-adjusted fair value of $232.02 (about 25% upside). The DCF ($217.74) and anchored P/E ($207.41) cluster in the $207-218 range and imply 12-18% upside, while the EPV floor of $130.40 says the no-growth downside is roughly 30% below spot - a wider downside than the base-case upside on the composite number, which is a yellow flag for margin of safety. Earnings quality is high, so no haircut is warranted, and the business-quality lens supports a premium multiple, but that premium appears mostly already reflected.
Verify before trusting this (4)
- FY25 organic revenue growth guide and bookings trend - the 3-4% growth assumption is central to the DCF
- Operating margin trajectory given AI automation pressure on staffing-based consulting
- Cash returns pace (buyback + dividend) vs the falling share count assumed in per-share math
- Any one-off restructuring or acquisition-related costs distorting reported earnings
The non-fundamental pressure on ACN has flipped constructive. The stock is up 26.7% in a month with a string of positive tape days (2026-07-28 buyback and dividend, 2026-07-29 Radisson agentic-AI win, 2026-08-19 rebound), and headlines are explicitly framing ACN as the preferred pick versus IBM on dividends and valuation. That is a real momentum-plus-relative-strength press for a steady-compounder name that normally trades on quiet flows. The narrative itself is shifting from 'AI disrupts consulting' toward 'AI drives consulting demand,' which is the single most important sentiment vector for this ticker. Macro backdrop is mildly supportive: risk-on tape, VIX 15, and a 1.07 beta means ACN participates in but is not levered to the regime. Rates at 4.69% and a 25.7 market PE are a low-grade drag on all equities but land softly on a defensive, cash-generative services name. Analyst tone appears to be catching up rather than leading, which leaves room for target revisions to add fuel. Net: a moderate, durable tailwind, not euphoria - the narrative intensity is only moderate and the cult coefficient is low, so this is a re-rating grind rather than a mania.
Verify before trusting this (4)
- Whether sell-side target revisions follow the price move or stay flat (a tell that the rally is retail/momentum, not institutional)
- Any client-budget commentary from peers (IBM, Infosys, Cognizant) that could revive the AI-disruption narrative
- Signs the risk-on regime holds beyond its 1-day print; a VIX spike would hit the momentum leg hardest
- Next quarterly bookings print - a soft managed-services number would puncture the AI-demand story fast
AI reaches Accenture on both sides of the same P&L line: demand-side it creates a large, multi-year integration and data-remediation program that only firms with existing enterprise access can execute, and Accenture is visibly winning that share; supply-side it attacks the cost basis of the very work it sells, because roughly half of revenue is managed services and offshore delivery whose price is anchored to headcount and labor arbitrage. Gross margin has sat at ~32% and operating margin ~15% for five years, which is the empirical signal that in a bid-driven services market productivity gains historically pass through to clients rather than to shareholders. So the decisive question is not capability — Accenture will ship good AI work — but whether it can re-price from time to outcome before AI-native, low-headcount challengers and hyperscaler/model-vendor professional services arms reset the reference price for a transformation program.
Verify before trusting this (8)
- Mix shift to outcome-based pricing
- Per-transaction BPO price resets
- Bookings-to-revenue conversion lag
- Headcount trend versus revenue
- Revenue per employee trajectory
- Share of asset/platform-based delivery
- Gross margin above 33%
- Operating margin above 16%
Enterprise technology spend is being redirected rather than expanded: budgets shift from discretionary transformation programs toward AI-enablement, data readiness and cost-takeout outsourcing. That mix shift favors the largest integrators with global delivery scale and existing Fortune 500 relationships, which is why a 3% industry supports a 7% ACN. The open question the world has not yet answered is whether AI ultimately expands the addressable scope of integration work or deflates its price; today it expands scope, but the labor-hours business model is the exposed surface. Macro is a modest brake on discretionary consulting, not a demand collapse — this is a steady, not cyclical-trough, backdrop.
When we made this prediction on Aug 23, 2026, ACN was $185.26. We expect it to be $205.75 by Feb 2027, and we consider it great value under $165.00. This is an early model (v0.6.0) — the direction is more reliable than the exact price. Made Aug 23, 2026.
Blue is our prediction, starting the day we made it. Grey is a slower route to the same place — the same destination, taking longer. Black is the actual price, so you can see how we are doing.